Removal of domain D2 or D3 of the human urokinase receptor does not affect ligand affinity

Leena Riittinen, Paola Limongi, Massimo P. Crippa, Massimo Conese, Luciano Hernandez-Marrero, Francesca Fazioli, Francesco Blasi

Research output: Contribution to journal › Article

18 Citations (Scopus)

Abstract

The main ligand-binding determinant of the human urokinase receptor (uPAR) is located in the amino terminal domain D1, but when isolated this domain presents a 1500 fold lower affinity than the intact three-domain uPAR (D1D2D3). uPAR mutants missing either domain 2 (D1HD3) or domain 3 (D1D2) were expressed in murine LB6 cells and showed to be properly GPI-anchored to the cell surface. Binding assays with [ 125I]ATF demonstrated that these mutants possessed a normal (D1D2) or slightly reduced (D1HD3) affinity, indicating that a high ligand-affinity may be achieved by a combination of D1 with domain D2 or D3.

Original languageEnglish
Pages (from-to)1-6
Number of pages6
JournalFEBS Letters
Volume381
Issue number1-2
DOIs
Publication statusPublished - Feb 26 1996

Fingerprint

Urokinase-Type Plasminogen Activator
Ligands
Assays

Keywords

  • GPI-anchored protein
  • uPA
  • Urokinase receptor

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Riittinen, L., Limongi, P., Crippa, M. P., Conese, M., Hernandez-Marrero, L., Fazioli, F., & Blasi, F. (1996). Removal of domain D2 or D3 of the human urokinase receptor does not affect ligand affinity. FEBS Letters, 381(1-2), 1-6. https://doi.org/10.1016/0014-5793(96)00033-6

Removal of domain D2 or D3 of the human urokinase receptor does not affect ligand affinity. / Riittinen, Leena; Limongi, Paola; Crippa, Massimo P.; Conese, Massimo; Hernandez-Marrero, Luciano; Fazioli, Francesca; Blasi, Francesco.

In: FEBS Letters, Vol. 381, No. 1-2, 26.02.1996, p. 1-6.

Research output: Contribution to journal › Article

Riittinen, L, Limongi, P, Crippa, MP, Conese, M, Hernandez-Marrero, L, Fazioli, F & Blasi, F 1996, 'Removal of domain D2 or D3 of the human urokinase receptor does not affect ligand affinity', FEBS Letters, vol. 381, no. 1-2, pp. 1-6. https://doi.org/10.1016/0014-5793(96)00033-6
Riittinen L, Limongi P, Crippa MP, Conese M, Hernandez-Marrero L, Fazioli F et al. Removal of domain D2 or D3 of the human urokinase receptor does not affect ligand affinity. FEBS Letters. 1996 Feb 26;381(1-2):1-6. https://doi.org/10.1016/0014-5793(96)00033-6
Riittinen, Leena ; Limongi, Paola ; Crippa, Massimo P. ; Conese, Massimo ; Hernandez-Marrero, Luciano ; Fazioli, Francesca ; Blasi, Francesco. / Removal of domain D2 or D3 of the human urokinase receptor does not affect ligand affinity. In: FEBS Letters. 1996 ; Vol. 381, No. 1-2. pp. 1-6.
@article{6bc549bc4c8b447f8c9e33be79d107ec,
title = "Removal of domain D2 or D3 of the human urokinase receptor does not affect ligand affinity",
abstract = "The main ligand-binding determinant of the human urokinase receptor (uPAR) is located in the amino terminal domain D1, but when isolated this domain presents a 1500 fold lower affinity than the intact three-domain uPAR (D1D2D3). uPAR mutants missing either domain 2 (D1HD3) or domain 3 (D1D2) were expressed in murine LB6 cells and showed to be properly GPI-anchored to the cell surface. Binding assays with [ 125I]ATF demonstrated that these mutants possessed a normal (D1D2) or slightly reduced (D1HD3) affinity, indicating that a high ligand-affinity may be achieved by a combination of D1 with domain D2 or D3.",
keywords = "GPI-anchored protein, uPA, Urokinase receptor",
author = "Leena Riittinen and Paola Limongi and Crippa, {Massimo P.} and Massimo Conese and Luciano Hernandez-Marrero and Francesca Fazioli and Francesco Blasi",
year = "1996",
month = "2",
day = "26",
doi = "10.1016/0014-5793(96)00033-6",
language = "English",
volume = "381",
pages = "1--6",
journal = "FEBS Letters",
issn = "0014-5793",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Removal of domain D2 or D3 of the human urokinase receptor does not affect ligand affinity

AU - Riittinen, Leena

AU - Limongi, Paola

AU - Crippa, Massimo P.

AU - Conese, Massimo

AU - Hernandez-Marrero, Luciano

AU - Fazioli, Francesca

AU - Blasi, Francesco

PY - 1996/2/26

Y1 - 1996/2/26

N2 - The main ligand-binding determinant of the human urokinase receptor (uPAR) is located in the amino terminal domain D1, but when isolated this domain presents a 1500 fold lower affinity than the intact three-domain uPAR (D1D2D3). uPAR mutants missing either domain 2 (D1HD3) or domain 3 (D1D2) were expressed in murine LB6 cells and showed to be properly GPI-anchored to the cell surface. Binding assays with [ 125I]ATF demonstrated that these mutants possessed a normal (D1D2) or slightly reduced (D1HD3) affinity, indicating that a high ligand-affinity may be achieved by a combination of D1 with domain D2 or D3.

AB - The main ligand-binding determinant of the human urokinase receptor (uPAR) is located in the amino terminal domain D1, but when isolated this domain presents a 1500 fold lower affinity than the intact three-domain uPAR (D1D2D3). uPAR mutants missing either domain 2 (D1HD3) or domain 3 (D1D2) were expressed in murine LB6 cells and showed to be properly GPI-anchored to the cell surface. Binding assays with [ 125I]ATF demonstrated that these mutants possessed a normal (D1D2) or slightly reduced (D1HD3) affinity, indicating that a high ligand-affinity may be achieved by a combination of D1 with domain D2 or D3.

KW - GPI-anchored protein

KW - uPA

KW - Urokinase receptor

UR - http://www.scopus.com/inward/record.url?scp=0030026674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030026674&partnerID=8YFLogxK

U2 - 10.1016/0014-5793(96)00033-6

DO - 10.1016/0014-5793(96)00033-6

M3 - Article

VL - 381

SP - 1

EP - 6

JO - FEBS Letters

JF - FEBS Letters

SN - 0014-5793

IS - 1-2

ER -

Access to Document